Skip to search form
Skip to main content
>
Semantic Scholar
Semantic Scholar's Logo
Search
Sign In
Create Free Account
You are currently offline. Some features of the site may not work correctly.
23-valent pneumococcal capsular polysaccharide vaccine
Known as:
23-valent vaccine
, pneumococcal polysaccharide PPV23
, PCV 23
Expand
National Institutes of Health
Create Alert
Related topics
Related topics
5 relations
Merck and Co., Inc.
Polyvalent pneumococcal vaccine
Narrower (2)
Pneumo-23
Pneumovax 23
Broader (1)
Pneumococcal vaccine
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Vaccination coverage and associated factors for receipt of the 23-valent pneumococcal polysaccharide vaccine in Taiwan
C. Chen
,
M. Wu
,
I-Chien Wu
Medicine
2018
Corpus ID: 3420456
Abstract Older adults, particularly those with chronic obstructive pulmonary disease, are advised to receive 23-valent…
Expand
2017
2017
Amélioration de la couverture vaccinale antipneumococcique chez les patients pris en charge pour une maladie systémique grâce à un programme de vaccination mené par les infirmières
J. Serre
,
T. Goulenok
,
+4 authors
K. Sacré
2017
Corpus ID: 80100868
Introduction Les patients suivis pour une maladie systemique et traites par immunosuppresseurs sont a risque eleve d’infection…
Expand
2016
2016
Vaccine profile of PPV23: Beijing Minhai Biotech 23-valent pneumococcal vaccine
Qi Liang
,
G. Li
,
F. Zhu
Expert review of vaccines
2016
Corpus ID: 28651712
ABSTRACT Introduction: Diseases caused by Streptococcus pneumoniae are a major public health problem worldwide, which can be…
Expand
Review
2015
Review
2015
Dosing regimen of the 23-valent pneumococcal vaccination: a systematic review.
Chelsea A. Caya
,
C. Boikos
,
S. Desai
,
C. Quach
Vaccine
2015
Corpus ID: 24594239
BACKGROUND Currently, one lifetime booster of a 23-valent pneumococcal polysaccharide vaccine (PPV23) is recommended for those at…
Expand
2014
2014
Immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine as a booster dose in 12- to 18-month-old children primed with 3 doses of 7-valent pneumococcal conjugate vaccine
U. Thisyakorn
,
K. Chokephaibulkit
,
P. Kosalaraksa
,
S. Benjaponpitak
,
C. Pancharoen
,
S. Chuenkitmongkol
Human vaccines & immunotherapeutics
2014
Corpus ID: 13225033
The current study examined the safety and immunogenicity of 23-valent pneumococcal capsular polysaccharide vaccine (Pneumo23…
Expand
Review
2012
Review
2012
Use of pneumococcal polysaccharide vaccine in children: what is the evidence?
R. Borrow
,
P. Heath
,
C. Siegrist
Current opinion in infectious diseases
2012
Corpus ID: 7153741
Purpose of review Pneumococcal glycoconjugate vaccines (PCVs) are now widely used in infant immunization schedules. These…
Expand
Review
2012
Review
2012
Benefits and effectiveness of administering pneumococcal polysaccharide vaccine with seasonal influenza vaccine: an approach for policymakers.
S. Gilchrist
,
A. Nanni
,
O. Levine
American journal of public health
2012
Corpus ID: 207274424
For the influenza pandemic of 2009-2010, countries responded to the direct threat of influenza but may have missed opportunities…
Expand
Highly Cited
2010
Highly Cited
2010
Concomitant administration of zoster and pneumococcal vaccines in adults ≥60 years old
C. R. MacIntyre
,
Tony Egerton
,
+9 authors
J. Silber
Human vaccines
2010
Corpus ID: 43327580
This study evaluated safety & immunogenicity of ZOSTAVAX® (zoster vaccine: ZV) administered concomitantly versus nonconcomitantly…
Expand
2008
2008
Inhaled delivery of 23-valent pneumococcal polysaccharide vaccine does not result in enhanced pulmonary mucosal immunoglobulin responses
S. Gordon
,
R. Malamba
,
+7 authors
N. French
Vaccine
2008
Corpus ID: 8844188
We compared the effect of intramuscular vs. inhaled 23-valent pneumococcal capsular polysaccharide vaccine (23-PPV) on pulmonary…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE